首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于雌激素受体通路探讨青娥丸对CUMS大鼠的抗抑郁机制
引用本文:宋珊珊,孙红,井汶,戴国梁,居文政.基于雌激素受体通路探讨青娥丸对CUMS大鼠的抗抑郁机制[J].中国实验方剂学杂志,2020,26(4):9-15.
作者姓名:宋珊珊  孙红  井汶  戴国梁  居文政
作者单位:南京中医药大学 附属医院, 南京 210029,南京中医药大学 附属医院, 南京 210029,南京中医药大学 附属医院, 南京 210029,南京中医药大学 附属医院, 南京 210029,南京中医药大学 附属医院, 南京 210029
基金项目:国家自然科学基金项目(81573685)
摘    要:目的:研究青娥丸对慢性温和不可预知应激模型(CUMS)大鼠的抗抑郁效果,及其对雌激素受体及相关信号通路的调控作用,探讨青娥丸的抗抑郁机制。方法:54只SD大鼠建立CUMS抑郁大鼠模型,实验设为正常组、模型组、草酸依他普伦组(6.3 mg·kg^-1)及青娥丸低、中、高剂量组(1.71,5.13,15.39 g·kg^-1)。CUMS造模4周后给予各组相应药物治疗2周,采用行为学糖水消耗实验(SPT),强迫游泳实验(FST),旷场实验(OFT)]评价大鼠抑郁状态;采用蛋白免疫印迹法(Western blot)检测雌激素受体α(ERα),雌激素受体β(ERβ),脑源性神经营养因子(BDNF)及酪氨酸激酶受体B(Trk B)的蛋白表达水平。结果:与正常组比较,模型组大鼠的糖水消耗率及旷场得分均下降(P<0.05,P<0.01),游泳不动时间显著延长(P<0.01),同时ERα,ERβ,BDNF和Trk B的蛋白表达水平下降(P<0.05,P<0.01);与模型组比较,各给药组大鼠的行为学表现得到改善,糖水消耗率及旷场得分增加(P<0.05,P<0.01),游泳不动时间减少(P<0.05),同时ERα,ERβ,BDNF和Trk B蛋白的表达明显上调(P<0.05,P<0.01),其中青娥丸中剂量组的调节作用更为显著。结论:青娥丸可改善CUMS模型大鼠的抑郁样行为,其机制可能与上调ERα,ERβ的表达,激活雌激素受体介导的ERβ/BDNF/Trk B通路起到神经保护作用有关。

关 键 词:青娥丸  慢性温和不可预知应激模型(CUMS)  抑郁  雌激素受体  雌激素受体β(ERβ)/脑源性神经营养因子(BDNF)/酪氨酸激酶受体B(TrkB)信号通路
收稿时间:2019/6/13 0:00:00

Anti-depressant Mechanism of Qing'ewan in CUMS Rats Based on Estrogen Receptor Pathway
SONG Shan-shan,SUN Hong,JING Wen,DAI Guo-liang and JU Wen-zheng.Anti-depressant Mechanism of Qing''ewan in CUMS Rats Based on Estrogen Receptor Pathway[J].China Journal of Experimental Traditional Medical Formulae,2020,26(4):9-15.
Authors:SONG Shan-shan  SUN Hong  JING Wen  DAI Guo-liang and JU Wen-zheng
Institution:Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China,Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China,Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China,Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China and Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
Abstract:Objective:To study the anti-depressive effect of Qing’ewan in treating chronic unpredictable mild stress(CUMS)in rats,and the regulatory effect on estrogen receptor and estrogen receptor-related signaling pathways,in order to explore its anti-depressive mechanism.Method:The CUMS model was established.The experiment was divided into normal control group,model group,escitalopram oxalate group(positive control)and Qing’ewan groups(1.71,5.13,15.39 g·kg^-1).After 4 weeks of modeling,rats were treated with corresponding drugs for 2 weeks.Behavioral evaluationsucrose preference test(SPT),forced swimming test(FST),open field test(OFT)]was conducted to assess if the CUMS model was successful.Western blot was used to analyze the protein expression levels of estrogen receptorα(ERα),estrogen receptorβ(ERβ),brain-derived neurotrophic factor(BDNF)and tyrosine kinase receptor B(TrkB).Result:Compared with the normal group,the sucrose consumption rate and the score of OFT in the model group decreased(P<0.05,P<0.01),the immobility time of FST prolonged significantly(P<0.01),and the protein expression levels of ERα,ERβ,BDNF and Trk B decreased(P<0.05,P<0.01).Compared with the model group,the behavioral performance of the treated group was improved,the sucrose consumption rate and the score of OFT increased(P<0.05,P<0.01),and the immobility time decreased(P<0.05).The protein expressions of ERα,ERβ,BDNF and TrkB in the treated group were significantly up-regulated(P<0.05,P<0.01),especially the middle-dose Qing’ewan group(5.13 g·kg^-1).Conclusion:Qing’ewan can improve depression-like behavior in CUMS rats.Its mechanism may be related to the neuroprotective effect by up-regulating the expressions of ERαand ERβand activating estrogen receptor-mediated ERβ/BDNF/TrkB pathways.
Keywords:Qing’ewan  chronic unpredictable mild stress(CUMS)  depression  estrogen receptor  estrogen receptorβ(ERβ)/brain-derived neurotrophic factor(BDNF)/tyrosine kinase receptor B(TrkB)pathway
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号